Replies to post #19476 on CytoSorbents Corporation (CTSO)

[KCRoyal2004]

So, $50/share would suggest a valuation of approximately $10B. I agree with you on your "annual flu" numbers, and assertions surrounding. Let's not forget; however, cardiac indication that is just emerging (including potential big pharma partnership), all of the other uses for Cytosorb not related to severe flu, and additional products in the pipeline with Cytosorbents. IF results of this indication are impressive enough, that will awake all of those sleeping giants out there (big pharma), that are really not aware of this quiet little company, to take notice. Food for thought....

[KCRoyal2004]

you might considers all that this company offers...https://cytosorb-therapy.com/en/infoitemmeta/endocarditis/

Borrowed from techxen reference on Stocktwits